hhvb glp 1 solución oral Who Shouldn't Take GLP-1 Medications? Beyond Ozempic: The GLP-1 boom
Description
Nature 535, 376381
Comparing Elevate Health to Other Telehealth GLP-1 Platforms The telehealth GLP-1 space grew crowded through 2024 and into 2025, with multiple platforms competing on price, medication options, and service features
Among people with type 2 diabetes, GLP-1 receptor agonist users show a lower incidence of Parkinson's disease (Brauer et al., 2020
Exon duplication and divergence in the human preproglucagon gene
The promise of GLP-1s to address these concerns is understandably appealing, but we lack adequate research to guide evidence-based prescribing and patient decisionmaking for this population
Very elderly, frail adults with limited life expectancy and high sarcopenia risk may suffer more harm than benefit from aggressive weight loss
